Investing Ideas
/
U.S. High Growth Potential Companies

U.S. High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1555

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

1,555 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
AXSM Axsome Therapeutics	US$90.67	-7.2%	28.5%	US$4.5b	US$130.47	PS13x	E72.5%	n/a	Pharmaceuticals & Biotech
ALKT Alkami Technology	US$37.94	-4.6%	62.0%	US$3.9b	US$44.60	PS12.1x	E98.6%	n/a	Software
TGTX TG Therapeutics	US$31.07	-1.8%	80.5%	US$4.8b	US$40.75	PS16.8x	E57.0%	n/a	Pharmaceuticals & Biotech
ONON On Holding	US$54.76	-5.9%	86.1%	US$18.1b	US$59.48	PE125.3x	E29.4%	n/a	Consumer Durables
ARES Ares Management	US$169.22	-7.3%	48.2%	US$55.8b	US$181.00	PE79x	E38.5%	2.2%	Diversified Financials
ZVRA Zevra Therapeutics	US$8.29	-6.2%	74.7%	US$452.6m	US$20.00	PS18.1x	E73.5%	n/a	Pharmaceuticals & Biotech
TVTX Travere Therapeutics	US$16.86	-9.7%	102.2%	US$1.5b	US$27.40	PS7.2x	E72.5%	n/a	Pharmaceuticals & Biotech
ALNY Alnylam Pharmaceuticals	US$237.92	-6.4%	32.9%	US$31.8b	US$299.11	PS14.6x	E70.3%	n/a	Pharmaceuticals & Biotech
SRPT Sarepta Therapeutics	US$120.25	-4.1%	33.2%	US$12.0b	US$183.60	PE94.3x	E42.5%	n/a	Pharmaceuticals & Biotech
EH EHang Holdings	US$13.94	-9.0%	-11.5%	US$924.6m	US$24.22	PS18.4x	E81.5%	n/a	Capital Goods
NVDA NVIDIA	US$128.91	-7.5%	167.9%	US$3.2t	US$172.38	PE50.1x	E25.1%	0.03%	Semiconductors
CRDO Credo Technology Group Holding	US$66.46	-2.9%	240.6%	US$11.1b	US$73.54	PS45.3x	E66.3%	n/a	Semiconductors
ATAT Atour Lifestyle Holdings	US$27.31	-1.7%	61.2%	US$3.9b	US$33.09	PE23.5x	E25.7%	1.6%	Consumer Services
OMF OneMain Holdings	US$51.42	-7.5%	5.8%	US$6.4b	US$59.00	PE11.2x	E31.2%	8.1%	Diversified Financials
LB LandBridge	US$53.48	-14.7%	n/a	US$4.2b	US$66.57	PE180x	E66.4%	0.7%	Real Estate Management and Development
NU Nu Holdings	US$10.40	-15.2%	28.4%	US$56.2b	US$15.54	PB6.5x	E28.6%	n/a	Banks
MRVL Marvell Technology	US$105.28	-5.5%	83.0%	US$97.1b	US$118.96	PS16.9x	E69.5%	0.2%	Semiconductors
IMGN ImmunoGen	US$31.23	6.6%	617.9%	US$8.4b	US$28.95	PS29.1x	E45.8%	n/a	Pharmaceuticals & Biotech
SGEN Seagen	US$228.74	4.5%	76.5%	US$43.2b	US$228.91	PS18.8x	E71.8%	n/a	Pharmaceuticals & Biotech
VCTR Victory Capital Holdings	US$61.19	-7.5%	79.7%	US$4.1b	US$70.00	PE14.9x	E31.5%	2.9%	Diversified Financials
ATLC Atlanticus Holdings	US$56.64	-8.6%	54.8%	US$864.9m	US$61.14	PE10.3x	E26.9%	n/a	Diversified Financials
TBBB BBB Foods	US$28.71	-4.0%	n/a	US$3.2b	US$34.29	PE251.6x	E41.5%	n/a	Consumer Retailing
ARDX Ardelyx	US$4.61	-13.3%	-22.4%	US$1.1b	US$10.78	PS4.3x	E69.6%	n/a	Pharmaceuticals & Biotech
ITCI Intra-Cellular Therapies	US$86.72	3.4%	32.8%	US$9.2b	US$103.50	PS15x	E69.2%	n/a	Pharmaceuticals & Biotech

Page 1 of 65